James O'Neill

James O'Neill has a diverse and extensive work experience in the investment banking industry. Currently, they hold the position of Managing Director and Co-Head of Healthcare Investment Banking & Head of Healthcare ECM at JonesTrading since September 2023.

Prior to this, they worked at Oppenheimer & Co. Inc. where they held various roles, including Head of Healthcare Equity Capital Markets from February 2021 to October 2022, Managing Director Investment Banking from February 2020 to September 2022, and Executive Director Investment Banking from April 2017 to February 2020.

Before joining Oppenheimer & Co. Inc., James worked at Roth Capital Partners as part of their Equity Capital markets team from July 2012 to March 2017. James also served as Vice President at Rodman & Renshaw from August 2010 to July 2012, Vice President at Cantor Fitzgerald from June 2009 to August 2010, and was involved in Equity Sales & Trading at Dahlman Rose & Co. (Acquired by Cowen Group, Inc.) from January 2005 to June 2009.

James O'Neill attended Manhattan College but did not complete a degree or specify a field of study.